Management of chronic diabetic foot ulcers using platelet-rich plasma
- PMID: 29244965
- DOI: 10.12968/jowc.2017.26.12.784
Management of chronic diabetic foot ulcers using platelet-rich plasma
Abstract
Objective: Platelet-rich plasma (PRP) has been proposed as an adjunct for the treatment of foot ulcers in patients with diabetes, as well as a treatment for chronic and acute wounds. This study examined the application of PRP in the treatment of diabetic foot ulcers (DFUs) in patients.
Methods: This prospective study was conducted between 2011 and 2014. We used PRP, produced by a kit, for the treatment of DFUs. Patients were allocated to one of three groups, according to size of ulcer. The significance of changes in time for wound healing were statistically assessed.
Results: The study was completed by 150 patients, and a total of 150 foot ulcers were assessed. Wound size reduction was detected in patients after four weeks of treatment. In DFUs with a 2-5.5 cm2 surface area, complete closure happened after 7.2 weeks, 5.5-8.5cm2 DFUs completely closed after 7.5 weeks, and 8.5-12.5cm2 DFUs healed completely after 8.8 weeks. None of the wounds reopened after eight months of monitoring.
Conclusions: This study will provide more evidence for the use of autologous PRP for DFUs in patients.
Keywords: diabetes; diabetic foot ulcer; platelet-rich plasma; platelets; wound healing.
Similar articles
-
Autologous platelet-rich plasma for treating chronic wounds.Cochrane Database Syst Rev. 2012 Oct 17;10:CD006899. doi: 10.1002/14651858.CD006899.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 May 25;(5):CD006899. doi: 10.1002/14651858.CD006899.pub3 PMID: 23076929 Updated. Review.
-
Role of platelet-rich plasma in healing diabetic foot ulcers: a prospective study.J Wound Care. 2018 Sep 2;27(9):550-556. doi: 10.12968/jowc.2018.27.9.550. J Wound Care. 2018. PMID: 30204574
-
Autologous platelet-rich plasma vs conventional dressing in the management of chronic diabetic foot ulcers.Wounds. 2022 Feb;33(2):36-42. doi: 10.25270/wnds/2022.3642. Wounds. 2022. PMID: 35108667
-
The Use of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Scoping Review.Cureus. 2023 Aug 14;15(8):e43452. doi: 10.7759/cureus.43452. eCollection 2023 Aug. Cureus. 2023. PMID: 37711926 Free PMC article. Review.
-
Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.Diving Hyperb Med. 2016 Sep;46(3):133-134. Diving Hyperb Med. 2016. PMID: 27723012
Cited by
-
Therapeutic potential of extracellular vesicle-associated long noncoding RNA.Bioeng Transl Med. 2020 Jul 16;5(3):e10172. doi: 10.1002/btm2.10172. eCollection 2020 Sep. Bioeng Transl Med. 2020. PMID: 33005738 Free PMC article. Review.
-
Role of platelet rich plasma mediated repair and regeneration of cell in early stage of cardiac injury.Regen Ther. 2022 Feb 15;19:144-153. doi: 10.1016/j.reth.2022.01.006. eCollection 2022 Mar. Regen Ther. 2022. PMID: 35229012 Free PMC article. Review.
-
Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review.Int J Mol Sci. 2023 Feb 8;24(4):3420. doi: 10.3390/ijms24043420. Int J Mol Sci. 2023. PMID: 36834843 Free PMC article. Review.
-
Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds.Exp Ther Med. 2018 Jun;15(6):5365-5370. doi: 10.3892/etm.2018.6131. Epub 2018 May 3. Exp Ther Med. 2018. PMID: 29904416 Free PMC article.
-
Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review.Front Endocrinol (Lausanne). 2023 Nov 18;14:1256081. doi: 10.3389/fendo.2023.1256081. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38169990 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
